NutraLife BioSciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.

Profit Margin

NutraLife BioSciences, Inc. (OTC:NLBS): Profit margin
2013 597.77K -2.08M -348.52%
2014 62.27K -2.07M -3333.2%
2015 193.99K -2.10M -1083.03%
2016 391.85K -1.52M -390.09%
2017 1.79M -23.62M -1319.94%
2018 3.71M -2.07M -55.9%
2019 2.13M -4.07M -190.91%
2020 1.25M -2.90M -231.15%
2021 626.61K -7.68M -1226.14%
2022 0 0

NLBS Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
0626.61K1.25M2.13M3.71M1.79M391.85K193.99K62.27K597.77K
Cost of revenue
0543.03K745.93K1.53M2.21M1.05M32.82K120.90K352.32K346.96K
Gross profit
083.58K509.85K598.13K1.50M735.12K359.03K73.09K-290.04K250.81K
Operating exp.
Research and development
0000000000
Selling and marketing
022.91K176.43K272.63K265.56K81.18K38.61K198.42K282.18K274.52K
Total operating expenses
04.55M2.48M3.99M3.40M21.02M1.42M1.74M1.34M2.26M
Operating income
0-4.47M-1.97M-3.39M-1.90M-20.28M-1.06M-1.66M-1.63M-2.01M
Other income (expenses), net
0-1.35M-916.88K-612.02K-34.74K-3.33M-465.14K-431.09K-445.27K-2
Income before tax
0-5.82M-2.88M-4.00M-2.07M-23.62M-1.52M-2.10M-2.07M-2.08M
Income tax expense
01.85M12.74K65.94K168.49K3.33M465.14K431.09K445.27K66.95K
Net income
0-7.68M-2.90M-4.07M-2.07M-23.62M-1.52M-2.10M-2.07M-2.08M
Earnings per share
Basic EPS
0-0.04-0.01-0.03-0.02-0.33-0.04-0.09-0.09-0.11
Diluted EPS
0-0.04-0.01-0.03-0.02-0.33-0.04-0.09-0.09-0.11
Data sourceData sourceData sourceData sourceData sourceData sourceData source